跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,089 条关于
“MEK-ERK”
全部
8,089
临床试验
6,741
药物
803
机构
66
资讯
479
去年
Neurofibromatoses Pipeline Shows Strong Activity with 12+ Therapies in Development Across Multiple Clinical Stages
去年
Blocking Nitrosylation: A Breakthrough Strategy for Treating Aggressive NRAS Melanoma
去年
Cosmos Health Acquires Rights to Two Patented Anticancer Drugs Targeting Multiple Cancers
8个月前
Verastem Discontinues KRAS G12C Trial to Focus on Promising G12D Inhibitor with 69% Response Rate
10个月前
Ono Pharmaceutical Secures Approvals for BRAFTOVI Combination Therapy in BRAF-Mutant Colorectal Cancer
11个月前
Pfizer's BRAFTOVI Plus MEKTOVI Achieves Nearly Four-Year Survival in BRAF-Mutant Lung Cancer
去年
Servier and Black Diamond Therapeutics Forge $780M Global Licensing Deal for Novel RAF/RAS Cancer Therapy
去年
RASAL2 Variant Identified as Novel Biomarker for Anti-EGFR Therapy Resistance in Colorectal Cancer
2年前
Combination Immunotherapy Strategies Show Promise in Overcoming NSCLC Treatment Resistance
去年
PD-1/PD-L1 Inhibitors Show Promise in Thyroid Cancer Treatment Through Combination Strategies
第 1 页,共 48 页
上一页
下一页